These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 10447962

  • 1. Cytotoxicity of 2,2':6',2' '-terpyridineplatinum(II) complexes against human ovarian carcinoma.
    Lowe G, Droz AS, Vilaivan T, Weaver GW, Park JJ, Pratt JM, Tweedale L, Kelland LR.
    J Med Chem; 1999 Aug 12; 42(16):3167-74. PubMed ID: 10447962
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
    Coley HM, Sarju J, Wagner G.
    J Med Chem; 2008 Jan 10; 51(1):135-41. PubMed ID: 18072719
    [Abstract] [Full Text] [Related]

  • 3. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR, Abel G, McKeage MJ, Jones M, Goddard PM, Valenti M, Murrer BA, Harrap KR.
    Cancer Res; 1993 Jun 01; 53(11):2581-6. PubMed ID: 8388318
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
    Kushev D, Gorneva G, Taxirov S, Spassovska N, Grancharov K.
    Biol Chem; 1999 Nov 01; 380(11):1287-94. PubMed ID: 10614821
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: a quantitative structure-activity relationship approach.
    Monti E, Gariboldi M, Maiocchi A, Marengo E, Cassino C, Gabano E, Osella D.
    J Med Chem; 2005 Feb 10; 48(3):857-66. PubMed ID: 15689170
    [Abstract] [Full Text] [Related]

  • 6. Platinum (II) complexes with stereochemically-defined thiepane dioxide diamine ligands as anticancer drugs.
    Cerè V, Grossi L, Munari D, Pollicino S, Martelli L, Martelli M.
    Anticancer Res; 2006 Feb 10; 26(3A):1815-9. PubMed ID: 16827112
    [Abstract] [Full Text] [Related]

  • 7. New synthetic route to [bis-1,2-(aminomethyl)benzene]dichloroplatinum(II) complexes, screening for cytotoxic activity in cisplatin-sensitive and resistant human cancer cell lines, and reaction with glutathione.
    Rinke K, Grünert R, Bednarski PJ.
    Pharmazie; 2001 Oct 10; 56(10):763-9. PubMed ID: 11683118
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis, characterization and antitumor activity of new type binuclear platinum(II) complexes.
    Zhang J, Liu L, Gong Y, Zheng X, Yang M, Cui J, Shen S.
    Eur J Med Chem; 2009 May 10; 44(5):2322-7. PubMed ID: 18524422
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Platinum(IV) complex with adamantylamine as nonleaving amine group: synthesis, characterization, and in vitro antitumor activity against a panel of cisplatin-resistant cancer cell lines.
    Zák F, Turánek J, Kroutil A, Sova P, Mistr A, Poulová A, Mikolin P, Zák Z, Kasná A, Záluská D, Neca J, Sindlerová L, Kozubík A.
    J Med Chem; 2004 Jan 29; 47(3):761-3. PubMed ID: 14736257
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
    Liu W, Chen X, Xie M, Lou L, Ye Q, Yu Y, Hou S.
    J Inorg Biochem; 2008 Oct 29; 102(10):1942-6. PubMed ID: 18707762
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The synthesis, characterisation and cytotoxicity of bisintercalating (2,2':6',2''-terpyridine)platinum(II) complexes.
    Harper BW, Aldrich-Wright JR.
    Dalton Trans; 2015 Jan 07; 44(1):87-96. PubMed ID: 25407567
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.